Emerging Infectious Disease ISSN: 1080-6059

Vaccine Effectiveness Estimates, 2004–2005 Mumps Outbreak, England

Cheryl Cohen*¹

, Joanne M. White†, Emma J. Savage†, Judith R. Glynn*, Yoon Choi†, Nick Andrews†, David Brown†, and Mary E. Ramsay†

Author affiliations: *London School of Hygiene and Tropical Medicine, London, United Kingdom; †Health Protection Agency Centre for Infections, London, United Kingdom; 1Current affiliations: National Institute for Communicable Diseases, Johannesburg, South Africa, and University of the Witwatersrand School of Public Health, Parktown, South Africa

Main Article

Figure 2

Estimates of 1-dose vaccine effectiveness for cases in 2004–05, assuming an increase in coverage of 0.04%–0.4% per year of age, which represents vaccination of approximately 1%–10% of unvaccinated persons per year of age. Values are offset on the x-axis so that 95% confidence intervals (CIs) are visible.

Figure 2. . Estimates of 1-dose vaccine effectiveness for cases in 2004–05, assuming an increase in coverage of 0.04%–0.4% per year of age, which represents vaccination of approximately 1%–10% of unvaccinated persons per year of age. Values are offset on the x-axis so that 95% confidence intervals (CIs) are visible.

Main Article

¹Current affiliations: National Institute for Communicable Diseases, Johannesburg, South Africa, and University of the Witwatersrand School of Public Health, Parktown, South Africa

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.